Dennis Karl Huang - Net Worth and Insider Trading
Dennis Karl Huang Net Worth
The estimated net worth of Dennis Karl Huang is at least $4 Million dollars as of 2024-09-21. Dennis Karl Huang is the See Remarks of Ultragenyx Pharmaceutical Inc and owns about 64,715 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $4 Million. Details can be seen in Dennis Karl Huang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dennis Karl Huang has not made any transactions after 2023-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dennis Karl Huang
Dennis Karl Huang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis Karl Huang owns 1 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) .
Click here to see the complete history of Dennis Karl Huang’s form 4 insider trades.
Insider Ownership Summary of Dennis Karl Huang
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2023-03-01 | SVP and Chief Tech Ops Officer |
Dennis Karl Huang Latest Holdings Summary
Dennis Karl Huang currently owns a total of 1 stock. Dennis Karl Huang owns 64,715 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 1, 2023, with a value of $4 Million.
Latest Holdings of Dennis Karl Huang
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2023-03-01 | 64,715 | 58.75 | 3,802,006 |
Holding Weightings of Dennis Karl Huang
Dennis Karl Huang Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennis Karl Huang has made a total of 6 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 389 shares on March 1, 2023, which brought Dennis Karl Huang around $17,758.
Insider Trading History of Dennis Karl Huang
- 1
Dennis Karl Huang Trading Performance
Dennis Karl Huang Ownership Network
Dennis Karl Huang Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Dennis Karl Huang is the SVP and Chief Tech Ops Officer of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include director & 10 percent owner & President & CEO Emil D Kakkis , Controller and PAO Theodore Alan Huizenga , and EVP and General Counsel Karah Herdman Parschauer .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Dennis Karl Huang made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .
In summary, during the past 3 months, insiders sold 40,675 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 40,675 shares. During the past 18 months, 257,334 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 257,334 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Dennis Karl Huang Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis Karl Huang. You might contact Dennis Karl Huang via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
